SCHEMBL14938007

SCHEMBL14938007

Cn1ncc(I)c1-c1cnn(-c2ccc(Cl)cc2)c1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 1/20 0.46
NOTUM Q6P988 1/20 0.38
MELK Q14680 4/20 0.37
GRM4 Q14833 1/20 0.36
MAPT P10636 2/20 0.36
NPC1 O15118 1/20 0.36
NFKB1 P19838 1/20 0.36
RAB9A P51151 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
KCNH2 Q12809 3/20 0.35
DRD4 P21917 5/20 0.34
HTR2C P28335 4/20 0.34
DRD2 P14416 1/20 0.34
DRD3 P35462 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14937840 0.86 GRM4 (0.46) MELKGRM4MAPTKCNH2DRD4
SCHEMBL14938051 0.83 MAPKAPK2 (0.50) MELKGRM4MAPTNPC1RAB9A
SCHEMBL14938263 0.82 NTRK1 (0.43) NOTUMMELKGRM4NPC1NFKB1
SCHEMBL14972973 0.79 MAP4K4 (0.51) MAP4K4NOTUMMELKGRM4MAPT
SCHEMBL14938236 0.74 MAP4K4 (0.48) MAP4K4NOTUMMELKGRM4MAPT
SCHEMBL14973279 0.73 RAB9A (0.49) MAP4K4MAPTNPC1RAB9ADRD4
SCHEMBL27834563 0.72 MAP4K4 (0.54) MAP4K4NOTUMGRM4MAPTNPC1
SCHEMBL14937976 0.68 HIF1A (0.42) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL9134518 0.68 ALDH1A1 (0.49) MAP4K4NOTUMMAPTNPC1NFKB1
SCHEMBL15555821 0.68 MAP4K4 (0.45) MAP4K4NOTUMMELKGRM4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8642626-B2 Ethinyl-pyrazole derivative TAISHO PHARMACEUTICAL CO., LTD. (JP) 2014-02-04 US disclosed
EP-2604602-A1 HETEROARYL-PYRAZOLE DERIVATIVE Taisho Pharmaceutical Co., Ltd. (JP) 2013-06-19 EP disclosed
EP-2599775-A1 ETHINYL-PYRAZOLE DERIVATIVE Taisho Pharmaceutical Co., Ltd. (JP) 2013-06-05 EP disclosed
US-20130137865-A1 HETEROARYL-PYRAZOLE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2013-05-30 US disclosed
US-20130123500-A1 ETHINYL-PYRAZOLE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD (JP) 2013-05-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130137865-A1 HETEROARYL-PYRAZOLE DERIVATIVE GRIN2C, GRIN2B, GRIN3A MAP4K4 2276/4885NOTUM 3066/4885MELK 972/4885
US-20130123500-A1 ETHINYL-PYRAZOLE DERIVATIVE GABRE, GRIN3A, GRIK5 MAP4K4 2087/4885NOTUM 3474/4885MELK 461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.